
26 – Electronic Records and Signatures Navigating 21 CFR Part 11 (S16E6)
About this episode
This episode examines the regulatory requirements governing electronic records and electronic signatures as outlined in 21 CFR Part 11. We discuss the critical aspects of system validation, audit trails, and security measures that are essential for ensuring electronic documentation aligns with cGMP standards. We also explain how digital systems can be seamlessly integrated into existing GMP frameworks, enabling reliable, secure, and compliant recordkeeping while preserving data integrity throughout a product's lifecycle. This discussion will explore the shift from paper-based systems to electronic systems and the implications of that transformation, particularly regarding data integrity and adherence to regulations.
Furthermore, we delve into the core requirements of 21 CFR Part 11, including system validation, audit trails, and security measures. We explain the importance of system validation in demonstrating accuracy, reliability, and consistent performance, highlighting its connection to equipment qualification processes like IQ, OQ, and PQ. The episode also details the requirements for audit trails, emphasizing their role in tracking changes, ensuring accountability, and supporting investigations. We discuss the need for secure access controls and physical security measures to protect sensitive electronic data. Finally, we explore the integration of Part 11 requirements with broader GMP principles, emphasizing the importance of written procedures, training, and a culture of quality in maintaining data integrity.
Get every episode summarized
Each time From Concept to Medicine - A Comprehensive Drug Development Journey publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from From Concept to Medicine - A Comprehensive Drug Development Journey

21 Atorvastatin (S24E21)
From Concept to Medicine - A Comprehensive Drug Development Journey

185 - Episode 5 - Good Documentation Practices (GDP) in Medical Devices - The AL...
From Concept to Medicine - A Comprehensive Drug Development Journey

20 Liraglutide (S24E20)
From Concept to Medicine - A Comprehensive Drug Development Journey

18 Pioglitazone (S24E18)
From Concept to Medicine - A Comprehensive Drug Development Journey